Management Of Placenta Previa Cases And Determination Of Hospitalization Criteria

Placenta Previa Clinical Trial

Official title:

Management Of Placenta Previa Cases And Determination Of Hospitalization Criteria

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04264234
• Other study ID #: 18-9.1/27
• Status: Completed
• Phase: N/A
• Start date: November 13, 2018
• Est. completion date: February 1, 2020

Study information

• Verified date: March 2022
• Source: Ege University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Placenta previa cases are one of the difficult groups of patients to manage in modern obstetrics. When the literature is evaluated extensively, no clear information can be seen especially in terms of hospitalization time. Inpatient follow-up of this patients has negative effects like hospital infections in terms of the patient, workload in terms of health personnel and financial losses in terms of the country's economy. Placenta previa cases are complicated patients in which generalizations cannot be easily performed and they should be monitored at third level hospitals. In addition, care should be personalized considering the many reasons. In this study, placenta previa cases will be followed up at 28th gestational week and evaluated at 32nd week by vaginal ultrasonography and MRI and this follow-up will continue until delivery. Thus, in this study, it was aimed to determine the parameters that would allow systematic personalization of health service in this particular patient group by making risk assessment of placenta previa cases.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 98
• Est. completion date: February 1, 2020
• Est. primary completion date: February 1, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Monitoring of placenta previa

• To apply before the 28th week

• To have a low-risk second trimester screening test

• No malformation detected in the anomaly screening

Exclusion Criteria:

• Multiple pregnancies

• Pregnancy complicated with preeclampsia

• Pregnancy complicated by gestational hypertension

• Pregnancy complicated by gestational diabetes mellitus

Related Conditions & MeSH terms

• Placenta Previa

Intervention

Diagnostic Test:
• Vaginal Ultrasonography
Placenta previa cases will be evaluated at 32nd week by vaginal ultrasonography for invasion anomaly and preterm birth.
• Magnetic Resonance Imaging
Placenta previa cases will be evaluated at 32nd week by MRI for invasion anomaly and preterm birth.

Locations

Country	Name	City	State
Turkey	Ege University Hospital	Izmir

Sponsors (1)

Lead Sponsor	Collaborator
Ege University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The number of placental invasion pathologies	Placental invasion pathologies detected during delivery will be evaluated.	1 day
Primary	The number of preterm birth	The relation between preterm birth and placental invasion pathologies will be assessed.	1 day